Trial Profile
A phase I trial of MW-001 for the treatment of multiple sclerosis
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 09 Aug 2016
Price :
$35
*
At a glance
- Drugs MW 001 (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 09 Aug 2016 New trial record